Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
- PMID: 9671775
- PMCID: PMC21173
- DOI: 10.1073/pnas.95.15.8892
Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
Abstract
Coenzyme Q10 is an essential cofactor of the electron transport chain as well as a potent free radical scavenger in lipid and mitochondrial membranes. Feeding with coenzyme Q10 increased cerebral cortex concentrations in 12- and 24-month-old rats. In 12-month-old rats administration of coenzyme Q10 resulted in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q10. Oral administration of coenzyme Q10 markedly attenuated striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increased life span in a transgenic mouse model of familial amyotrophic lateral sclerosis. These results show that oral administration of coenzyme Q10 increases both brain and brain mitochondrial concentrations. They provide further evidence that coenzyme Q10 can exert neuroprotective effects that might be useful in the treatment of neurodegenerative diseases.
Figures







Similar articles
-
Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.Mol Aspects Med. 1997;18 Suppl:S169-79. doi: 10.1016/s0098-2997(97)00024-1. Mol Aspects Med. 1997. PMID: 9266519
-
Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.Biofactors. 1999;9(2-4):261-6. doi: 10.1002/biof.5520090222. Biofactors. 1999. PMID: 10416039 Review.
-
Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.Neuroscience. 1996 Apr;71(4):1043-8. doi: 10.1016/0306-4522(95)00527-7. Neuroscience. 1996. PMID: 8684608
-
Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.Brain Res Bull. 2006 Jun 15;70(1):22-32. doi: 10.1016/j.brainresbull.2005.11.019. Epub 2005 Dec 27. Brain Res Bull. 2006. PMID: 16750479
-
Coenzyme Q10 as a possible treatment for neurodegenerative diseases.Free Radic Res. 2002 Apr;36(4):455-60. doi: 10.1080/10715760290021315. Free Radic Res. 2002. PMID: 12069110 Review.
Cited by
-
A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases.Int J Mol Sci. 2021 Mar 20;22(6):3168. doi: 10.3390/ijms22063168. Int J Mol Sci. 2021. PMID: 33804658 Free PMC article. Review.
-
The Emerging Roles of Ferroptosis in Huntington's Disease.Neuromolecular Med. 2019 Jun;21(2):110-119. doi: 10.1007/s12017-018-8518-6. Epub 2019 Jan 2. Neuromolecular Med. 2019. PMID: 30600476 Review.
-
Huntington's disease: the coming of age.J Genet. 2018 Jul;97(3):649-664. J Genet. 2018. PMID: 30027901 Review.
-
Compartment specific mitochondrial dysfunction in Drosophila knock-in model of ALS reversed by altered gene expression of OXPHOS subunits and pro-fission factor Drp1.Mol Cell Neurosci. 2023 Jun;125:103834. doi: 10.1016/j.mcn.2023.103834. Epub 2023 Mar 1. Mol Cell Neurosci. 2023. PMID: 36868541 Free PMC article.
-
The clinical trial landscape in amyotrophic lateral sclerosis-Past, present, and future.Med Res Rev. 2020 Jul;40(4):1352-1384. doi: 10.1002/med.21661. Epub 2020 Feb 11. Med Res Rev. 2020. PMID: 32043626 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical